2017
DOI: 10.1016/j.jaapos.2017.07.216
|View full text |Cite
|
Sign up to set email alerts
|

Ophthalmic findings in Frank-ter Haar syndrome: report of a sibling pair

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
11
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 13 publications
(11 citation statements)
references
References 7 publications
0
11
0
Order By: Relevance
“…Most examined individuals with an SH3PXD2B or MMP14 mutation had a broad mouth, as well as one third of examined patients with an MMP2 mutation. Finally, thick lips and either a small or heavy mandible have been reported in most examined patients with an SH3PXD2B , MMP14 , or MMP2 mutation (Al Aqeel et al, ; Al Kaissi et al, ; Azzollini et al, ; Bader‐Meunier et al, ; Bendon et al, ; Bhavani et al, ; Borrone et al, ; Castberg et al, ; Chang et al, ; Eisenstein et al, ; Ekbote et al, ; Gok et al, ; Hamel et al, ; Iqbal et al, ; Jeong et al, ; Maas et al, ; Martignetti et al, ; Mégarbané et al, ; Phadke & Dalal, ; Pichler et al, ; Prapanpoch et al, ; Rouzier et al, ; Temtamy et al, ; Ter Haar et al, ; Tuysuz et al, ; Vanatka et al, ; Van Steensel et al, ; Wilson et al, ; Winchester et al, ; Zankl et al, ; Zankl et al, ; Zrhidri et al, ).…”
Section: Discussion and Reviewmentioning
confidence: 99%
See 2 more Smart Citations
“…Most examined individuals with an SH3PXD2B or MMP14 mutation had a broad mouth, as well as one third of examined patients with an MMP2 mutation. Finally, thick lips and either a small or heavy mandible have been reported in most examined patients with an SH3PXD2B , MMP14 , or MMP2 mutation (Al Aqeel et al, ; Al Kaissi et al, ; Azzollini et al, ; Bader‐Meunier et al, ; Bendon et al, ; Bhavani et al, ; Borrone et al, ; Castberg et al, ; Chang et al, ; Eisenstein et al, ; Ekbote et al, ; Gok et al, ; Hamel et al, ; Iqbal et al, ; Jeong et al, ; Maas et al, ; Martignetti et al, ; Mégarbané et al, ; Phadke & Dalal, ; Pichler et al, ; Prapanpoch et al, ; Rouzier et al, ; Temtamy et al, ; Ter Haar et al, ; Tuysuz et al, ; Vanatka et al, ; Van Steensel et al, ; Wilson et al, ; Winchester et al, ; Zankl et al, ; Zankl et al, ; Zrhidri et al, ).…”
Section: Discussion and Reviewmentioning
confidence: 99%
“…Gingival hypertrophy has been reported in ≥50% of examined individuals with an SH3PXD2B , MMP14 , or MMP2 mutation (Table ). Delayed dentition, attributed to gingival hypertrophy, was less frequently reported (Al Aqeel et al, ; Bader‐Meunier et al, ; Bhavani et al, ; Borrone et al, ; Chang et al, ; Eisenstein et al, ; Ekbote et al, ; Martignetti et al, ; Mégarbané et al, ; Phadke & Dalal, ; Prapanpoch et al, ; Temtamy et al, ; Tuysuz et al, ; Van Steensel et al, ; Wilson et al, ; Winchester et al, ; Zankl et al, ).…”
Section: Discussion and Reviewmentioning
confidence: 99%
See 1 more Smart Citation
“…Besides, the reported phenotype-genotype correlations have shown inconsistent and inconclusive findings (2,3,7,12,19). Some authors include Ter Haar syndrome (FTHS [MIM # 249420]) which is caused by homozygous mutation in the TKS4 gene among the MONA syndrome spectrum disorders (20)(21)(22)(23)(24). The autosomal dominant rare multicentric carpotarsal osteolysis syndrome (MCTO [MIM # 166300]) with or without nephropathy is another important differential diagnosis of MONA syndrome (25)(26)(27)(28)(29)(30).…”
Section: Introductionmentioning
confidence: 99%
“…Besides, the reported phenotype-genotype correlations have shown inconsistent and inconclusive findings ( de Vos et al, 2019 ; Bhavani et al, 2016 ; Kröger et al, 2019 ; Rouzier et al, 2006 ; Azzollini et al, 2014 ). Some authors include Ter Haar syndrome (FTHS [MIM # 249420 ]) which is caused by homozygous mutation in the TKS4 gene among the MONA syndrome spectrum disorders ( Chang et al, 2017 ; Bendon et al, 2012 ; Iqbal et al, 2010 ; van Steensel et al, 2007 ; Borrone et al, 1993 ). The autosomal dominant rare multicentric carpotarsal osteolysis syndrome (MCTO [MIM # 166300 ]) with or without nephropathy is another important differential diagnosis of MONA syndrome ( Li et al, 2020 ; Park et al, 2018 ; Upadia et al, 2018 ; Stajkovska et al, 2018 ; Mumm et al, 2014 ; Zankl et al, 2012 ).…”
Section: Introductionmentioning
confidence: 99%